USA – Moderna says its COVID-19 vaccine works effectively against variants

US-based Moderna has reported that its COVID-19 vaccine seems to work effectively against new variants of the coronavirus discovered in the UK and South Africa.

The early laboratory studies, which have not yet been peer-reviewed, showed that individuals vaccinated with the Moderna COVID-19 vaccine demonstrated activity against both strains of SARS-CoV-2.

According to the company, the vaccine produced neutralising antibody titers against ‘all key emerging variants’ – including the UK’s B117 and South Africa’s B1351 variants.

Although the study found no significant impact on antibodies against the B117 variant, a six-fold reduction in neutralising antibodies against the B1351 variant was observed – relative to prior variants…